HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,464.80
Day range
₹1,417.10 - ₹1,459.90
Year range
₹815.85 - ₹1,593.90
Market cap
195.03B INR
Avg Volume
194.13K
P/E ratio
59.57
Dividend yield
0.51%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.22B | 49.36% |
Operating expense | 3.76B | 42.03% |
Net income | 836.30M | -18.60% |
Net profit margin | 11.58 | -45.51% |
Earnings per share | 6.14 | -18.57% |
EBITDA | 2.11B | 35.48% |
Effective tax rate | 25.16% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.43B | 27.24% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 31.77B | — |
Shares outstanding | 135.98M | — |
Price to book | 7.19 | — |
Return on assets | — | — |
Return on capital | 7.15% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 836.30M | -18.60% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,620
